AGIO Live signaler | Maksimer profitt med Getagraph.com

KJøP 111416 min ago

@ $25.84

Utstedt: 14 feb 2024 @ 19:56

Avkastning: 30.26%

Forrige signal: feb 14 - 15:30

Forrige signal: Selg

Avkastning: 1.31 %

Live Chart Being Loaded With Signals

Commentary (1 mai 2024 @ 22:00):

Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology...

Stats
Dagens volum	842 309
Gjennomsnittsvolum	760 100
Markedsverdi	1.87B
EPS	$-1.720 ( 2024-02-21 )
Neste inntjeningsdato	( $-1.640 ) 2024-05-02
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-8.59
ATR14	$0.0670 (0.20%)

Insider Trading

Date	Person	Action	Amount	type
2024-04-08	Fouse Jacqualyn A	Buy	15 934	Common stock
2024-04-10	Fouse Jacqualyn A	Sell	7 791	Common stock
2024-04-08	Fouse Jacqualyn A	Sell	15 934	Restricted stock units
2024-03-07	Foster-cheek Kaye I	Sell	1 285	Common stock
2024-03-05	Foster-cheek Kaye I	Sell	300	Common stock

INSIDER POWER
24.99
Last 100 transactions
Buy: 882 792 \| Sell: 538 174

Volum Korrelasjon

Lang: -0.38 (neutral)

Kort: -0.65 (weak negative)

Signal:(29.031) Neutral

Agios Pharmaceuticals Inc Korrelasjon

10 Mest positive korrelasjoner
NEOG	0.95
LSXMA	0.941
EAR	0.94
VORB	0.94
LSXMK	0.94
STAF	0.938
VERU	0.936
TTOO	0.936
OCC	0.935
ACCD	0.935

10 Mest negative korrelasjoner
EBSB	-0.952
PAE	-0.944
RMRM	-0.935
THRN	-0.933
SERA	-0.925
CYT	-0.924
BWC	-0.921
ZGNX	-0.919
MLTX	-0.919
GXII	-0.918

Visste du det?

Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).

Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.

Agios Pharmaceuticals Inc Korrelasjon - Valuta/Råvare

0.25
( neutral )

-0.02
( neutral )

0.00
( neutral )

0.17
( neutral )

0.04
( neutral )

Agios Pharmaceuticals Inc Økonomi

Annual	2023
Omsetning:	$26.82M
Bruttogevinst:	$17.32M (64.57 %)
EPS:	$-6.33

FY	2023
Omsetning:	$26.82M
Bruttogevinst:	$17.32M (64.57 %)
EPS:	$-6.33

FY	2022
Omsetning:	$14.24M
Bruttogevinst:	$12.54M (88.03 %)
EPS:	$-1.360

FY	2021
Omsetning:	$0.00
Bruttogevinst:	$0.00 (0.00 %)
EPS:	$26.55

Financial Reports:

No articles found.

Agios Pharmaceuticals Inc

Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and AG-946 that is in Phase I clinical study for treating hemolytic anemias and other indications. Agios Pharmaceuticals, Inc. was incorporated in 2007 and is headquartered in Cambridge, Massachusetts.

Sanntidsoppdatering for Agios Pharmaceuticals Inc [AGIO]

Upcoming Earnings Alert